Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients
Status:
Completed
Trial end date:
2018-07-11
Target enrollment:
Participant gender:
Summary
This is an open-label study in advanced solid tumor patients to determine if entrectinib
affects the pharmacokinetics of midazolam and any of its pharmacologically active
metabolites.